SOBI and 0MTD Related Headlines

Go Back

Jan 7, 2026 12:41PM Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data
Jul 15, 2025 01:40PM The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under incentive programmes

SOBI and 0MTD Related Press Releases

Go Back

Jan 7, 2026 12:41PM Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data
Jul 15, 2025 01:40PM The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under incentive programmes

SOBI and 0MTD Related SEC Filings

Go Back